|
Delayed
Toronto S.E.
09:30:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 4.400 CAD | 0.00% |
|
+7.06% | +285.96% |
| 09-28 | Medicure Inc. Completes Enrollment In Its MEND-PNPO Phase 3 Clinical Trial | CI |
| 09-09 | Medicure Presents Mend-Pnpo Phase 3 Study Design and Baseline Data At the 16Th European Epilepsy Congress | CI |
| Market Cap | 45.92M 32.72M 29.2M 26.94M 24.48M 3.1B 46.63M 325M 128M 1.62B 123M 120M 5.14B | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 42.98M 30.62M 27.33M 25.21M 22.91M 2.9B 43.64M 304M 120M 1.52B 115M 112M 4.81B | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
72.7% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MPH | Delayed | |
OTC Markets
| MCUJF | Delayed | |
|
Deutsche Boerse AG
| NGQ1 | Delayed | |
|
Börse Stuttgart
| NGQ1 | Delayed | |
|
Boerse Muenchen
| NGQ1 | Real-time |
Last Transcript: Medicure Inc.
| 1 week | +7.06% | ||
| Current month | +54.93% | ||
| 1 month | +60.58% | ||
| 3 months | +289.38% | ||
| 6 months | +388.89% | ||
| Current year | +285.96% |
| 1 week | 4.24 |  | 4.44 |
| 1 month | 2.63 | | 4.95 |
| Current year | 0.85 | | 4.95 |
| 1 year | 0.85 | | 4.95 |
| 3 years | 0.63 | | 4.95 |
| 5 years | 0.63 | | 4.95 |
| 10 years | 0 | | 10.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 1997-09-14 |
James Kinley
DFI | Director of Finance/CFO | 48 | 2011-07-14 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 2019-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 1997-09-14 |
Arnold Naimark
BRD | Director/Board Member | 93 | 2000-02-27 |
Brent Fawkes
BRD | Director/Board Member | 56 | 2013-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/30/26 | Option | Chief Technology Officer | -20,000 | 0.1916% | ||
| 3/28/25 | Option | Chief Financial Officer | 1,350 | 0.0129% | ||
| 3/28/25 | Option | Chief Technology Officer | 7,500 | 0.0719% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +7.06% | +300.00% | +144.44% | 32.65M | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +3.27% | +10.46% | +73.74% | 55.2B | |
| +0.74% | +4.04% | +12.18% | +91.76% | 52.79B | |
| -0.41% | +1.49% | +26.27% | +49.74% | 45.53B | |
| -1.05% | +2.11% | +21.83% | +126.39% | 43.94B | |
| -3.93% | -0.80% | +254.38% | +922.88% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +4.94% | +38.23% | +28.03% | 23.51B | |
| Average | -1.76% | +3.39% | +74.17% | +155.88% | 38.87B | |
| Weighted average by Cap. | -1.82% | +3.43% | +47.77% | +159.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 21.91M 15.61M 13.93M 12.85M 11.68M 1.48B 22.24M 155M 61M 775M 58.59M 57.33M 2.45B | 28.86M 20.56M 18.35M 16.93M 15.38M 1.95B 29.3M 204M 80.34M 1.02B 77.17M 75.52M 3.23B |
| Net income | -1.04M -740K -661K -610K -554K -70.12M -1.05M -7.34M -2.89M -36.74M -2.78M -2.72M -116M | -7.1M -5.06M -4.51M -4.16M -3.78M -479M -7.21M -50.16M -19.76M -251M -18.98M -18.57M -795M |
| Net Debt | -6.32M -4.5M -4.02M -3.71M -3.37M -426M -6.41M -44.65M -17.59M -223M -16.89M -16.53M -708M | -2.94M -2.1M -1.87M -1.73M -1.57M -199M -2.99M -20.81M -8.2M -104M -7.87M -7.7M -330M |
Employees
38
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | $4.400 | 0.00% | 836 |
| 26-10-21 | $4.400 | 0.00% | 2,655 |
| 26-10-20 | $4.400 | +2.33% | 6,710 |
| 26-10-19 | $4.300 | +1.18% | 9,317 |
| 26-10-16 | $4.250 | +3.41% | 14,702 |
- Stock Market
- Stocks
- MPH Stock
Select your edition
All financial news and data tailored to specific country editions
